Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-EN Version v19-FR
Language English French
Date Updated 2019-02-16 2019-02-15
Drug Identification Number 00328154 00328154
Brand name ATROPINE SULFATE INJECTION USP ATROPINE SULFATE INJECTION USP
Common or Proper name ATROPINE SULFATE INJECTION USP ATROPINE SULFATE INJECTION USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients ATROPINE SULFATE ATROPINE SULFATE
Strength(s) 0.1MG 0.1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 10mL LifeShield 10 x 10mL LifeShield
ATC code A03BA A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-11-16 2018-11-16
Estimated end date
Actual end date 2019-02-15 2019-02-15
Shortage status Resolved Actual shortage
Company comments
Health Canada comments